Blood substitutes
Blood substitutes have long been sought after, and artificial oxygen carriers may soon become a reality. Despite increased safety of allogeneic blood in terms of transmission of infectious diseases [1], avoiding allogeneic blood transfusions remains an important goal in perioperative and intensive care medicine. This is because allogeneic blood transfusions may cause immunosuppression with an increased incidence of postoperative infections [2,3] and may adversely affect outcome in intensive care [4], and thus they remain a public concern [5].
Complete Metadata
| bureauCode |
[ "009:25" ] |
|---|---|
| identifier | https://healthdata.gov/api/views/6iff-9rfa |
| issued | 2025-07-14 |
| landingPage | https://healthdata.gov/d/6iff-9rfa |
| programCode |
[ "009:048" ] |
| theme |
[ "NIH" ] |
